studiedDrug

47 triples

GPTKB property

testedDrug

Subject	Object
gptkb:Adaptive_COVID-19_Treatment_Trial_1	gptkb:remdesivir
gptkb:ECHO-301/KEYNOTE-252_trial	gptkb:epacadostat
gptkb:JUPITER_trial	gptkb:rosuvastatin
gptkb:PACIFIC_trial	gptkb:durvalumab
gptkb:DESCARTES_trial	gptkb:evolocumab
gptkb:Solidarity_trial	gptkb:interferon_beta-1a
gptkb:CheckMate_227	gptkb:nivolumab
gptkb:VISION_trial	177Lu-PSMA-617
gptkb:Canakinumab_Anti-inflammatory_Thrombosis_Outcomes_Study	gptkb:canakinumab
gptkb:COVID-19_Solidarity_Trial_(WHO)	gptkb:lopinavir/ritonavir
gptkb:ROCKET_trial	gptkb:rivaroxaban
gptkb:Solidarity_trial	hydroxychloroquine
gptkb:Solidarity_trial	gptkb:remdesivir
gptkb:Prospective_Comparison_of_ARNI_with_ACEI_to_Determine_Impact_on_Global_Mortality_and_Morbidity_in_Heart_Failure	gptkb:sacubitril/valsartan
gptkb:Oxygent_Clinical_Trials	Oxygent
gptkb:IMpower150	paclitaxel
gptkb:Justification_for_the_Use_of_Statins_in_Prevention:_an_Intervention_Trial_Evaluating_Rosuvastatin	gptkb:rosuvastatin
gptkb:Rivaroxaban_Once_Daily_Oral_Direct_Factor_Xa_Inhibition_Compared_with_Vitamin_K_Antagonism_for_Prevention_of_Stroke_and_Embolism_Trial_in_Atrial_Fibrillation	gptkb:rivaroxaban
gptkb:SURPASS-3	gptkb:tirzepatide
gptkb:Solidarity_trial	gptkb:lopinavir/ritonavir